Twist Bioscience Corporation (TWST)
NASDAQ: TWST · Real-Time Price · USD
124.72
-3.99 (-3.10%)
At close: Sep 4, 2026, 4:00 PM EDT
125.40
+0.68 (0.55%)
After-hours: Sep 4, 2026, 7:30 PM EDT
Twist Bioscience Stock Forecast
Stock Price Forecast
According to 11 analysts polled by S&P Global, Twist Bioscience stock has a consensus rating of "Buy" and an average price target of $105.3. The average 1-year stock price forecast is 15.57% lower than the current stock price, while the lowest is $36 (-71.14%) and the highest is $120 (-3.78%).
Price Target: $105.3 (-15.57%)
Analyst Consensus: Buy
Price Target
Chart* Price targets were last updated on Aug 5, 2026.
Analyst Ratings
The average analyst rating for Twist Bioscience stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Mar '26 | Apr '26 | May '26 | Jun '26 | Jul '26 | Aug '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 7 | 7 | 8 | 8 | 7 | 7 |
| Buy | 1 | 1 | 1 | 2 | 2 | 2 |
| Hold | 2 | 2 | 1 | 1 | 2 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 10 | 10 | 10 | 11 | 11 | 11 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Piper Sandler | Piper Sandler | Buy Reiterates $115 | Buy | Reiterates | $115 | -7.79% | Aug 5, 2026 |
| Canaccord Genuity | Canaccord Genuity | Buy Maintains $120 | Buy | Maintains | $120 | -3.78% | Aug 4, 2026 |
| Robert W. Baird | Robert W. Baird | Buy Maintains $113 → $115 | Buy | Maintains | $113 → $115 | -7.79% | Aug 4, 2026 |
| William Blair | William Blair | Buy Reiterates n/a | Buy | Reiterates | n/a | n/a | Aug 3, 2026 |
| TD Cowen | TD Cowen | Buy Reiterates $89 → $115 | Buy | Reiterates | $89 → $115 | -7.79% | Aug 3, 2026 |
Financial Forecast
Revenue This Year
456.29M
from 376.57M
Increased by 21.17%
Revenue Next Year
539.23M
from 456.29M
Increased by 18.18%
EPS This Year
-0.60
from -2.12
EPS Next Year
-0.63
from -0.60
EPS and Forward PE are based on non-GAAP adjusted numbers.